- Home
- CLYM vs MPU Comparison
CLYM vs MPU Comparison
Compare CLYM & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLYM
- MPU
- Stock Information
- Founded
- CLYM 2018
- MPU 1989
- Country
- CLYM United States
- MPU Singapore
- Employees
- CLYM N/A
- MPU N/A
- Industry
- CLYM
- MPU Transportation Services
- Sector
- CLYM
- MPU Consumer Discretionary
- Exchange
- CLYM NYSE
- MPU Nasdaq
- Market Cap
- CLYM 83.8M
- MPU 78.8M
- IPO Year
- CLYM 2021
- MPU 1998
- Fundamental
- Price
- CLYM $1.49
- MPU $4.08
- Analyst Decision
- CLYM Buy
- MPU
- Analyst Count
- CLYM 1
- MPU 0
- Target Price
- CLYM $10.00
- MPU N/A
- AVG Volume (30 Days)
- CLYM 210.7K
- MPU 1.6M
- Earning Date
- CLYM 08-13-2025
- MPU 08-13-2025
- Dividend Yield
- CLYM N/A
- MPU N/A
- EPS Growth
- CLYM N/A
- MPU N/A
- EPS
- CLYM N/A
- MPU N/A
- Revenue
- CLYM N/A
- MPU $35,228,600.00
- Revenue This Year
- CLYM N/A
- MPU N/A
- Revenue Next Year
- CLYM N/A
- MPU N/A
- P/E Ratio
- CLYM N/A
- MPU N/A
- Revenue Growth
- CLYM N/A
- MPU 305.32
- 52 Week Low
- CLYM $1.05
- MPU $0.49
- 52 Week High
- CLYM $8.87
- MPU $4.44
- Technical
- Relative Strength Index (RSI)
- CLYM N/A
- MPU 75.49
- Support Level
- CLYM N/A
- MPU $3.36
- Resistance Level
- CLYM N/A
- MPU $4.44
- Average True Range (ATR)
- CLYM 0.00
- MPU 0.44
- MACD
- CLYM 0.00
- MPU 0.16
- Stochastic Oscillator
- CLYM 0.00
- MPU 87.11
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.